Holen Sie sich die Stockscreener-App
37.00
2.17%
1.00
Schlusskurs vom Vortag:
$36.00
Offen:
$37.4575
24-Stunden-Volumen:
70,662
Relative Volume:
3.04
Marktkapitalisierung:
$145.96M
Einnahmen:
$17,000
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-11.86
EPS:
-3.12
Netto-Cashflow:
$-22.03M
1W Leistung:
-6.46%
1M Leistung:
+18.61%
6M Leistung:
+100.87%
1J Leistung:
+115.09%
1-Tages-Spanne:
$34.98
$37.46
1-Wochen-Bereich:
$34.40
$39.66
52-Wochen-Spanne:
$14.00
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Firmenname
Vtv Therapeutics Inc
Sektor
Branche
Telefon
336-841-0300
Adresse
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
37.06 | 141.77M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.36 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
724.67 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.19 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.66 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-23 | Eingeleitet | Roth Capital | Buy |
| 2026-01-05 | Eingeleitet | TD Cowen | Buy |
| 2025-11-19 | Eingeleitet | BTIG Research | Buy |
| 2019-05-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-04-10 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Eingeleitet | Northland Capital | Outperform |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-09-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-08-24 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vtv Therapeutics Inc Aktie (VTVT) Neueste Nachrichten
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737 - Yahoo Finance
Discipline and Rules-Based Execution in VTVT Response - Stock Traders Daily
VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst - Seeking Alpha
VTVT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
vTv Therapeutics Inc. (NASDAQ:VTVT) Short Interest Up 61.2% in February - MarketBeat
VTVT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VTVT PE Ratio & Valuation, Is VTVT Overvalued - Intellectia AI
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength - TipRanks
vTv Therapeutics posts updated investor presentation highlighting Phase 3 cadisegliatin readout and $118.5M liquidity - TradingView
vTv Therapeutics (VTVT) spotlights cadisegliatin Phase 3 and cash runway - Stock Titan
VTVT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Quarterly Earnings: Can US Physical Therapy Inc deliver consistent EPS growth2025 Earnings Impact & Breakout Confirmation Trade Signals - baoquankhu1.vn
What are analysts’ price targets for vTv Therapeutics Inc.2025 Retail Activity & Short-Term Trading Opportunity Alerts - mfd.ru
Can vTv Therapeutics Inc. sustain earnings growthProfit Target & Long-Term Safe Investment Plans - mfd.ru
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Stock Analysis: What are analysts price targets for vTv Therapeutics IncMarket Activity Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
vTv Therapeutics (VTVT) CFO granted 44,969 stock options at $36.92 - Stock Titan
Behavioral Patterns of VTVT and Institutional Flows - Stock Traders Daily
What’s next for vTv Therapeutics Inc. stockMarket Trend Report & AI Powered Buy/Sell Recommendations - mfd.ru
Why vTv Therapeutics Inc. stock could see breakout soonJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - mfd.ru
vTv Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Type 1 diabetes drug developer vTv set for two investor conferences - Stock Titan
Will vTv Therapeutics Inc. stock recover after earningsShort Setup & Stock Portfolio Risk Management - mfd.ru
Is vTv Therapeutics Inc.’s ROE strong enoughQuarterly Growth Report & Smart Allocation Stock Reports - mfd.ru
Aug Retail: Does vTv Therapeutics Inc have strong fundamentalsEarnings Overview Report & Stepwise Swing Trade Plans - baoquankhu1.vn
(VTVT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Q1 EPS Forecast for vTv Therapeutics Increased by Analyst - Defense World
HC Wainwright Boosts Earnings Estimates for vTv Therapeutics - MarketBeat
Will vTv Therapeutics Inc outperform the market in YEARQuarterly Trade Report & Stepwise Trade Signal Guides - baoquankhu1.vn
Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS) - The Globe and Mail
vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma By Investing.com - Investing.com India
vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma - Investing.com Australia
vTv Therapeutics Expands Global HPP737 Rights with Newsoara - TipRanks
vTv Therapeutics Signs License Agreement Amendment With Newsoara Biopharma - TradingView
vTv expands Newsoara license deal for PDE4 inhibitor to global rights - Investing.com India
VTVT Expands Global Rights Agreement for PDE4 Inhibitor - GuruFocus
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewswire
Analysts Set vTv Therapeutics Inc. (NASDAQ:VTVT) Price Target at $55.25 - Defense World
VIX Spike: Is vTv Therapeutics Inc likely to announce a buybackMarket Volume Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Published on: 2026-01-29 06:19:41 - baoquankhu1.vn
VTVT: BTIG Raises Price Target to $49.00, Maintains Buy Rating | - GuruFocus
How (VTVT) Movements Inform Risk Allocation Models - Stock Traders Daily
vTv Therapeutics (NASDAQ:VTVT) Upgraded to Strong-Buy at Roth Mkm - MarketBeat
This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Roth Capital Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
Roth/MKM initiates coverage on vTv Therapeutics stock with Buy rating - Investing.com Canada
Roth Capital Initiates Coverage on VTVT with a 'Buy' Rating | VT - GuruFocus
Buyout Rumor: Does vTv Therapeutics Inc have declining or rising EPSWeekly Gains Summary & Verified Momentum Stock Alerts - baoquankhu1.vn
Published on: 2026-01-19 16:04:02 - baoquankhu1.vn
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):